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1. Introduction {#s0005}
===============

Coronaviruses are enveloped, positive-sense, single-stranded RNA viruses that can infect both animals and humans ([@bb0165]; [@bb0230]). They comprise the largest group of viruses under the order *Nidovirales*, which includes the families *Coronaviridae*, *Arteriviridae*, *Roniviridae* and *Mesoviridae*. The *Coronaviridae* family consists of two subfamilies: *Coronavirinae* and *Torovirinae*. The *Coronavirinae* are classified into four genera: *Alphacoronavirus*, *Betacoronavirus*, *Gammacoronavirus*, and *Deltacoronavirus* ([@bb0305]; [@bb0395]). Four coronaviruses have been identified to cause infections in humans so far, namely the alphacoronaviruses HCoV-NL63 and HCov-229E, and the betacoronaviruses HCoV-OC43 and HCoV-HKU1, which are endemic and known to cause common colds and severe lower respiratory tract infections ([@bb0020]; [@bb0700]). Together, these four coronaviruses are responsible for 15 to 30% of all common colds ([@bb0430]). The genus *Betacoronavirus* is further classified in four subgenera: *Embecovirus*, *Sarbecovirus*, *Merbecovirus* and *Nobecovirus*. ([@bb0210]; [@bb0360]).

Just seventeen years ago, the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) emerged in southern China in 2002 and caused the SARS epidemic of 2002--3, that affected 33 countries, resulted in 8422 confirmed cases and 916 deaths. Currently, there is no known SARS-CoV transmission anywhere in the world. The latest human cases of SARS-CoV infection were reported in China in April 2004 in an outbreak that resulted from laboratory-acquired infections ([@bb0110]). About a decade later, the Middle East Respiratory Syndrome coronavirus (MERS-CoV) emerged as a dangerous human disease in the Arabian Peninsula in 2012 ([@bb0005]; [@bb0300]; [@bb0360]; [@bb0545]). At the end of January 2020, a total of 2519 laboratory-confirmed cases of Middle East respiratory syndrome (MERS) had been reported globally, including 866 deaths with a case-fatality rate of 34.3%. The majority of these cases were reported from Saudi Arabia (2121 cases), including 788 deaths with a case-fatality rate of 37.1% ([@bb0650]). In December 2019, a new coronavirus emerged and was named SARS-CoV-2 by the International Committee for Taxonomy of Viruses, and the disease it causes named COVID-19 by the World Health Organization ([@bb0010]; [@bb0210]). Phylogenetic analysis showed that this novel coronavirus has 79--79.5% genetic similarity with SARS-CoV, and 50% with MERS-CoV, being sufficiently different from SARS-CoV to be classified as a new *Betacoronavirus* belonging to the *Sarbecovirus* subgenus ([@bb0130]; [@bb0400]; [@bb0525]; [@bb0720]).

Studies on the modes of transmission of SARS-CoV-2 have shown that it is primarily transmitted through close personal contacts with respiratory droplets or aerosols from an infected person, which can be generated during sneezing, coughing, and exhalation ([@bb0455]; [@bb0550]). This is why frequent hand-washing and maintaining a distance of at least one meter are considered the main precautions against contracting the infection ([@bb0015]; [@bb0440]). In addition to that, several studies have reported that SARS-CoV airborne transmission was the main transmission route in indoor cases studied in Hong Kong\'s Prince of Wales Hospital ([@bb0345]; [@bb0675]; [@bb0705]), health care facilities in Canada ([@bb0100]) and in aircraft ([@bb0470]). Considering the many similarities between the two SARS viruses and the evidence on virus transport in general, it is highly likely that the SARS-CoV-2 virus also spreads by air ([@bb0440]). A recent study by [@bb0590] supports this hypothesis by showing that SARS-CoV-2 remained viable in aerosols for 3 h (the duration of the experiment), confirming that aerosol and fomite transmission of the virus is plausible as the virus can remain infectious and viable in aerosols for hours.

Another suggested transmission route is the fecal-oral one, as viable SARS-CoV-2 has been detected in stools of COVID-19 patients ([@bb0610]; [@bb0670]; F. [@bb0680]) and virus RNA has been found in sewage ([@bb0025]; [@bb0280]; [@bb0420]; [@bb0510]), which may be overlooked in a hospital setting because it is not a commonly discussed source of pathogenic aerosols ([@bb0415]). This could be used to identify the early-warning signs and scale of an outbreak, as monitoring wastewater could provide better estimates for how widespread the virus is than testing due to the fact that wastewater surveillance can account for those who have not been tested and have only mild or no symptoms ([@bb0405]).

Next, we will discuss viral, host and environmental factors that favor SARS-CoV, MERS-CoV and SARS-CoV-2 zoonotic spillover and transmission to humans.

2. The zoonotic origins of SARS-CoV, MERS-CoV and SARS-CoV-2 {#s0010}
============================================================

The concept of species barrier in infectious diseases comes from the fact that the relationship between infectious agents such as viruses and their host species is restricted by genetic adaptations that develop through co-evolution of the virus and its host species, and when spillover of these viruses occur, development of severe disease in the new hosts might occur, as the virus is not adapted to the new host ([@bb0625]). Alphacoronavirus and betacoronaviruses infect only mammals, whereas gammacoronavirus and deltacoronavirus infect mainly birds ([@bb0060]; [@bb0080]). Bats and birds are the main animal reservoirs of infection of coronaviruses ([@bb0645]), from which they can be transmitted to other animals that live near or in close contact with humans, such as domestic pets or exotic animals sold in Chinese wet markets destined for human consumption ([@bb0115]; [@bb0625]). During this journey, they either undergo genetic mutations and acquire new genes, or modify existing genes through recombination mechanisms ([@bb0635]). These changes in their genomes result in adaptations that make them more suitable to cross the species barrier, such as the changes in the Spike protein (S) in the receptor-binding domain (RBD) that contributed to the adaptation of SARS-CoV ([@bb0495]; [@bb0665]) and MERS-CoV to human cells ([@bb0140]; [@bb0180]).

2.1. SARS-CoV {#s0015}
-------------

The initial studies investigating animal sources of the virus from wet markets in the Guangdong province of China suggested that Himalayan palm civets (*Paguma larvata*) and raccoon dogs (*Nyctereutes procyonoides*) were the probable hosts responsible for human transmission ([@bb0225]) because genetically similar coronaviruses were isolated from them. However, it has been reported that masked palm civets from the wild or farms without exposure to the live animal markets were mostly negative for SARS-CoV ([@bb0320]), suggesting that masked palm civets only served as the intermediate amplifying host ([@bb0700]). It has also been demonstrated that SARS-CoV can infect macaques, ferrets and cats, however it only produced disease in the first two ([@bb0185]; [@bb0410]).

On later studies, a SARS-like coronavirus (BatCov RaTG13) that closely matched the human SARS-CoV was isolated from the Chinese horseshoe bat (*Rhinolophus affinis*) and was able to replicate in HeLa cells expressing the angiotensin-converting enzyme 2 (ACE2) receptor from humans, civets and bats ([@bb0200]). This RaTG13 and other bat SARS-CoV-related coronaviruses ([@bb0295]; [@bb0355]) share 88--92% nucleotide sequence homology with SARS- CoV-1 ([@bb0700]), leading scientists to believe that SARS-CoV was transmitted directly to humans from wet market civets, with bats as the main reservoir hosts ([@bb0145]; [@bb0255]).

2.2. MERS-CoV {#s0020}
-------------

Dromedary camels are thought to be the primary zoonotic reservoir for human transmission, with strong evidence that bats are the evolutionary source of this coronavirus ([@bb0055]; [@bb0120]; [@bb0225]; [@bb0620]). Furthermore, it was demonstrated that MERS-CoV can infect bat cells by exploiting the dipeptidyl peptidase-4 (DPP4), the same receptor used to infect human cells ([@bb0505]; [@bb0530]).

It is not known when MERS-CoV spread from bats to camels, but widespread exposure to the virus in the Middle East and North/East Africa dates back as early as the 1980s, suggesting that camels have served as a zoonotic reservoir for MERS-CoV for at least 30 years ([@bb0045]; [@bb0135]; [@bb0145]; [@bb0450]; [@bb0520], [@bb0515]). However, questions still remain as many confirmed cases of MERS have no contact history with camels before developing symptoms ([@bb0535]), most likely being a result of human-to-human transmission or unknown transmission routes involving unrecognized animal species that carry MERS-CoV ([@bb0700]).

2.3. SARS-CoV-2 {#s0025}
---------------

Up until recently, the main suspect of being the intermediate host for SARS-CoV-2 was the pangolin, as several studies have identified SARS-CoV-2-related viruses in Malayan pangolins (*Manis javanica*) ([@bb0290]; [@bb0380]; [@bb0630]; [@bb0685], [@bb0690]; [@bb0715]), but genetic analyses did not find any conclusive proof ([@bb0150]; [@bb0290]; [@bb0715]). SARS-CoV-2 that was isolated from infected individuals showed a higher similarity to the BatCov RaTG13 virus than to the ones that were isolated from the pangolins ([@bb0370]). In addition to that, the Guangdong pangolin coronaviruses have a higher amino acid identity (97.4%) with SARS-CoV-2 than the bat coronavirus RaTG13 (89.2%) in the RBD ([@bb0235]; [@bb0290]; [@bb0380]; [@bb0630]; K. [@bb0685]; [@bb0715]). In the rest of the genome, RaTG13 possess a higher sequence identity with SARS-CoV-2 than the Guangdong pangolin coronaviruses, with phylogenetic analysis based on the synonymous sites of the RBD showing that RaTG13 is more closely related to SARS-CoV-2 than Guandong\'s pangolin coronaviruses ([@bb0235]; [@bb0290]; [@bb0380]; [@bb0630]; K. [@bb0685]; [@bb0715]). Based on these evidences, three hypotheses were suggested for the link of pangolins with SARS-CoV-2: (i) pangolins are the intermediate host, and SARS-CoV-2 emerged from the spillover from pangolins to humans once; (ii) pangolins are the intermediate host, and SARS-CoV-2 emerged from the spillover from pangolins to humans multiple times; (iii) SARS-CoV-2 and pangolin CoVs originated independently through cross-species transmission from bats ([@bb0235]).

Information about the SARS-CoV-2 virus in other animals is scarce until this date, with SARS-CoV-2 being isolated from dogs, cats, tigers and minks in only a few sporadic cases ([@bb0655]). Other cases have been reported in other countries such as Belgium, the Netherlands, France, Germany, Russia, and Spain, affecting different domestic animals or mink farms. These reported episodes evidence that while felines and dogs can be infected by SARS-CoV-2, only felines can develop symptoms. However, it remains unclear if any domestic or livestock species can spread the virus to humans ([@bb0245]). Moreover, the susceptibility of ferrets and other domestic animals to SARS-CoV-2 has also been demonstrated in experimental infections ([@bb0270]). SARS-CoV-2 cannot replicate well in dogs, pigs, chickens, and ducks, but it can replicate efficiently in ferrets and cats, and be transmitted between cats via respiratory droplets ([@bb0555]).

[Fig. 1](#f0005){ref-type="fig"} shows the zoonotic origins as well as the intermediate hosts for SARS-CoV, MERS-CoV and SARS-CoV-2.Fig. 1The zoonotic origins and intermediate hosts for SARS-CoV, MERS-CoV and SARS-CoV-2.Fig. 1

3. Viral and host factors that favor transmission {#s0030}
=================================================

Disease outbreaks such as the 2002--2003 SARS epidemic and the current COVID-19 pandemic are the result of several factors, including higher mutation rates of RNA viruses and the unique capacity for genetic recombination of the positive-sense RNA genomes of coronaviruses ([@bb0115]; [@bb0265]; [@bb0550]).

Coronaviruses encode the largest single-stranded positive-sense RNA genomes among RNA viruses (27--32 kb), with at least six open reading frames (ORFs), namely ORF1ab, spike, envelope, membrane and nucleocapsid ([@bb0215]; [@bb0445]; [@bb0485]; [@bb0565]; [@bb0640]). These large genomes account for their diversity, leading to greater plasticity and greater chances to adapt to different hosts, being an advantage for host switching and interspecies infection ([@bb0640]). Their diversity has been attributed to two main factors: the low fidelity of their RNA-dependent RNA polymerase (RdRp) and the high frequency of their homologous RNA recombination ([@bb0165]; [@bb0260]; [@bb0640]).

3.1. The low fidelity of RNA-dependent RNA polymerase (RdRp) {#s0035}
------------------------------------------------------------

Coronaviruses have high genetic variability and this is mainly due to their high mutation rates resulting from the low fidelity of the RdRp, which is associated with the capacity of these viruses to adapt to many different hosts and their rapid evolution ([@bb0540]; [@bb0560]). The low fidelity of the RdRp results in unusually high mutation rates, generally estimated as 10^3^ to 10^5^, giving coronaviruses plasticity to adapt to new environmental pressures and host changes ([@bb0095]; [@bb0115]; [@bb0640]).

In contrast to other positive-sense RNA viruses, coronaviruses replicate with higher fidelity, and all larger members of the *Nidovirales* order encode a 3′-to-5′ exoribonuclease (ExoN) domain that is required for replication fidelity and is a probable RNA-dependent RNA proof-reading enzyme ([@bb0155]; [@bb0285]). This might have allowed for genome expansion and may also be responsible for fast virus evolution in face of changes in ecological settings and maintenance of RNA transcription fidelity ([@bb0155]; [@bb0485]; [@bb0540]). When ExoN is inactivated in engineered SARS-CoV genomes, viruses can exhibit a 10-fold or higher increase in mutation frequency, up to 18 times higher than those tolerated for fidelity mutants of other RNA viruses, suggesting that ExoN probably acts as a proof reading enzyme and is required for fidelity regulation and maintenance of these large genomes ([@bb0165]; [@bb0215]; [@bb0540]). The discovery of ExoN\'s function as a regulator of replication fidelity might indicate that RNA genome replication fidelity can adapt to different environmental settings and selective pressures, which would allow for rapid virus evolution in changing ecologic conditions ([@bb0095]; [@bb0155]; [@bb0215]).

3.2. The high frequency of homologous RNA recombination {#s0040}
-------------------------------------------------------

It has been proposed that coronaviruses have a special random template switching mediated by a 'copy-choice' mechanism during RNA replication. This process is divided in two stages: genome replication and subgenomic RNA transcription ([@bb0095]; [@bb0125]; [@bb0195]; [@bb0275]; [@bb0500]). In the first stage, the plus-strand genome RNA is transcribed into a full-length minus-strand template RNA, from which more plus-strand genome RNAs are synthesized. In the second stage, 3′-nested subgenomic RNAs are transcribed and used as templates for the translation of viral proteins ([@bb0155]). Due to the low capacity of the RdRp to copy the same template, the RNA replicase complex must pause and switch from the original template to the acceptor template during synthesis ([@bb0125]; [@bb0195]). This acceptor RNA must be in close proximity for the switch to take place, and it also needs to present sequence similarity to allow the RdRp to bind and continue RNA synthesis ([@bb0285]; [@bb0490]; [@bb0560]). In the case of coronaviruses, mRNA synthesis occurs in a discontinuous manner, in which the RNA replicase complex jumps between positions in the genome. This mechanism involves frequent template switching during replication, leading to frequent recombination events ([@bb0480]).

The viral RdRp recognizes the transcriptional regulatory sequences (TRSs) that are located upstream of each subgenomic ORF during negative strand synthesis ([@bb0155]; [@bb0355]). The polymerase has two options at these points: it can read through to the next TRS or dissociate from the template strand and reassociate with the leader TRS that is in the 5′ UTR ([@bb0155]; [@bb0215]). Then, it completes synthesis of a set of subgenomic negative strand RNA containing an antileader RNA sequence the same size as each viral mRNA. These subgenomic negative strand RNAs function as the main templates to produce subgenomic mRNAS that are 3′-coterminal with an \~70 nt 5′ leader sequence. Therefore, alterations in TRS sequences can influence viral replication efficiency ([@bb0155]). Combined, all these factors have given coronaviruses more plasticity to accommodate and modify genes ([@bb0700]), which is evidenced by the numerous unique open reading frames (ORFs) and protein functions encoded towards the 3′ end of the genome ([@bb0095]; [@bb0475]; [@bb0640]; [@bb0700]).

Besides the low fidelity of coronaviruses RdRp, their high frequency of homologous recombination and genetic diversity, another key determinant of interspecies transmission and host specificity of SARS-CoV-like viruses is the interaction of the spike (S) protein with the host receptor angiotensin-converting enzyme 2 (ACE2) ([@bb0330]; [@bb0595]). "*The S protein of SARS-CoV, MERS-CoV, and SARS- CoV-2 has 1104 to 1273 amino acids and contains an amino (N)- terminal S1 subunit and a carboxyl (C)-terminal S2 subunit* ([@bb0385]; [@bb0660]) ([Fig. 2](#f0010){ref-type="fig"} ). *In the S1 subunit, the receptor-binding domain (RBD), spanning about 200 residues, consists of two subdomains: the core and external subdomains* ([@bb0350]; [@bb0390]). *The RBD core subdomain is responsible for the formation of S trimer particles* ([@bb0710]). *The external subdomain contains two exposed loops on the surface, which bind with ACE2* ([@bb0315])" ([@bb0385]).Fig. 2Structural diagrams of S (spike) glycoproteins of SARS-CoV, MERS-CoV, and SARS-CoV-2. The spike proteins contain S1 and S2 subunits, which are divided by the S cleavage sites. FP: fusion peptide; HR: heptad repeat 1 and heptad repeat 2; RBD: receptor-binding domain, contains core binding motif in the external subdomain; SP: signal peptide. Image adapted from [@bb0385]. *Journal of Medical Virology*, DOI: (<https://doi.org/10.1002/jmv.25726>).Fig. 2

Recently, it has been shown that SARS-CoV-2 has a polybasic cleavage site (RRAR) at the junction of S1 and S2, which allows effective cleavage by furin and other proteases and has a role in determining viral infectivity and host range ([@bb0460]). A leading proline is also inserted at this site in SARS-CoV-2 (PRRA), creating a turn that is predicted to result in the addition of O-linked glycans to S673, T678 and S686, which flank the cleavage site and are unique to SARS-CoV-2 ([@bb0050]). The functional implications of this polybasic cleavage site and the addition of O-linked glycans is still unknown. Previous experiments with SARS-CoV have shown that insertion of a furin cleavage site at the S1--S2 junction enhances cell--cell fusion without affecting viral entry ([@bb0175]), and efficient cleavage of the MERS-CoV spike enabled MERS-like coronaviruses from bats to infect human cells ([@bb0425]). Regarding the addition of O-linked glycans, it has been suggested that it might play a role in protein folding and immune evasion ([@bb0050]; [@bb0065]; [@bb0615]).

The infection of humans by SARS-CoV-like viruses depends on specific genetic changes in the S1\'s RBD. These changes are thought to have been achieved by continuous evolution independent of recombination, in which the bat-CoV ancestor virus ability to bind human ACE2 was acquired or improved by point mutations when it infected intermediate hosts before it could efficiently infected humans, which is supported by the existence of at least 3 discontinuous highly variable genomic regions between SARS-CoV and SARS-CoV like viruses ([@bb0600]). To enter host cells, a defined RBD in the S1 subunit of the S protein needs to specifically recognize the host receptor\'s ACE2 for docking and entry, thus making the RBD and the ACE2 the key determinants of cross-species and human-to-human transmission of SARS-CoV-like viruses ([@bb0335]; [@bb0340]; [@bb0595]).

The S protein of the SARS-CoV-2 is thought to be modified via homologous recombination, being the result of a mixture of bat SARS-CoV and an unknown betacoronavirus ([@bb0365]; [@bb0550]). It has been shown that SARS-CoV-2 uses the same ACE2 cell receptor and entry mechanism as previously described for SARS-CoV ([@bb0220]; [@bb0365]; [@bb0695]), the latter being capable of recognizing and binding to the ACE2 receptors of other animal species including bats, palm civets and raccoon dogs, giving us a lead on how the events leading to SARS-CoV-2 interspecies transmission might have taken place ([@bb0115]).

Major species barriers between humans and mice, rats or bats have been recently reviewed by. By using human ACE2 as the reference molecule, key residue changes in these animal\'s ACE2 molecules that disfavor SARS-CoV binding were identified. Mice have been found to support SARS-CoV infections inefficiently, rats have showed to be resistant to SARS-CoV infections and the Daubenton\'s bat (*Myotis daubentonii*) supports SARS-CoV infections at low levels, showing that critical residue changes between human ACE2 and mouse, rat, or bat ACE2 pose as major species barriers for SARS-CoV infections ([@bb0330]).

Similar to SARS-CoV-2 and SARS-CoV, host cell entry in MERS-CoV is mediated by binding of the S protein to another cell receptor, namely the host dipeptidyl peptidase 4 (DDP4) receptor, and variation in this receptor has been shown to block cell entry in host cells ([@bb0585], [@bb0580]). Viral adaptation of MERS-CoV to the bat species *Desmodus rotundus* DPP4 was shown by demonstrating that the S protein of MERS-CoVcan make use of multiple paths to rapidly adapt to novel species, once again highlighting the capacity of coronaviruses for host-switching ([@bb0310]).

Before fusion, the S protein also needs to be cleaved by host cellular proteases ([@bb0095]; [@bb0395]), such as the human airway trypsin-like protease (HAT), cathepsins and transmembrane protease serine 2 (TMPRSS2) ([@bb0090]; [@bb0550]). These cellular factors are also important in defining host specificity and must also be taken into consideration. Other factors such as the innate immune response, metabolic characteristics and restriction factors of host cells that either increase or decrease viral replication still need to be elucidated for complete understanding of SARS-CoV-2\'s mechanisms of infection and pathogenicity. The divergence of these host factors between humans and the natural and intermediate hosts of coronaviruses might elucidate how cross-species infections occur and what might be the barriers to cross-species transmission ([@bb0700]).

4. Environmental factors that favor transmission {#s0045}
================================================

Mankind has already been through three epidemiological disruptions ([@bb0435]). The first one goes back to when humans were hunter-gatherers many thousand years ago. We were never in one place long enough and settlements were not large enough to sustain the transmission of infectious diseases, but this changed with the advent of the agriculture and the arrival of permanent settlements in the Middle East during the Neolithic revolution ([@bb0250]). This led to the domestication of animals and the establishment of larger permanent human settlements, which in turn facilitated the spread of bacteria and viruses between cattle and humans ([@bb0190]). The next two disruptions are linked to urbanization and commercial trade and resulted in pandemic influenzas, viral hemorrhagic fevers in animals and humans, and antimicrobial resistance -- all of which are linked to environmental and socioeconomic factors and frequent contact between humans and animals ([@bb0030]; [@bb0435]; [@bb0465]).

Because humans are now living in an interconnected and globalized world, greater human mobility is leading to an increase in the frequency and reach of infectious diseases epidemics. People can go from one location to virtually any other point on the planet in only 1--2 days, bringing with them the diseases they carry and potentially causing the dissemination of emerging and re-emerging infectious diseases that may pose a threat to global health security ([@bb0170]), as seen with the current global spread of COVID-19.

Just like SARS-CoV and MERS-CoV, SARS-CoV-2 also emerged in China. The reasons China seems to be the hotspot for emerging viral diseases are the increase in population and mobility, as well as the increased cultural demand for food and animals in wildlife trade ([@bb0375]). The presence of many different species of animals in cages near one another in wet-markets and the fact that these markets are located near residential areas in most parts of China allow frequent contacts between humans and these animals that might be carrying new viral diseases, providing an ideal scenario for the emergence of novel viruses that can cross the species barriers ([@bb0115]; [@bb0375]; [@bb0635]).

Other factors that contribute to interspecies infections are deforestation and altered ecosystems (which result in viral deprivation of their natural hosts, therefore providing the basis for human infection), illegal wildlife trading, intensive domestic animal husbandry, and large-scale distribution of uncontrolled food of animal origin ([@bb0105]; [@bb0130]; [@bb0225]).

5. Why are bats the main reservoirs of infection for emerging viruses? {#s0050}
======================================================================

Bats seem to be the main reservoir hosts for a lot of coronaviruses like SARS-CoV, MERS-CoV and SARS-CoV-2. First of all, bats are a very diverse order of mammals (Order Chiroptera), with approximately 1240 species (20% of the nearly 5000 known species within Mammalia) ([@bb0240]; [@bb0575]). One in every four species of mammals on earth is a bat, and they can be found in every continent with an exception of the polar regions and some oceanic islands, which means there is a good chance that a virus would come from a bat just because they are so diverse and have a broad geographic distribution ([@bb0625]). A bat can also live up to twenty years, and this can facilitate the persistence of infectious agents, thereby increasing the chance of spreading these infectious agents by natural or accidental dispersal of bats into new geographical areas, as they can fly over a relatively large distance from their roosting sites in search for food or during migration ([@bb0600]; [@bb0625]).

Another important aspect is the fact that they live in large communities (ranging from 10 to 200,000 bats) in very close proximity to one another, which in addition to their social habits creates the perfect environment for passing viruses within their communities ([@bb0625]). In addition to that, their immune system seems to be less able to clean viruses, leading to asymptomatic infection and viral persistence ([@bb0115]; [@bb0325]; [@bb0600]), which is indicative of a highly evolved relationship between bats and the viruses they carry ([@bb0605]). Some bat species also have the habit of hibernating over winter to save energy ([@bb0205]). With a reduced body temperature and lower metabolic rates, they may temporarily fail to create an antibody response to infection, leading to delay in virus clearance from their organisms ([@bb0115]; [@bb0240]; [@bb0605]).

It has been suggested that early control of viral replication by the innate immune response of bats through IFN responses followed by a generally slower peak of T-cell response might be the key mechanism to explain the absence of symptomatic disease in infected bats ([@bb0075]). Another special feature of their immune system relies in the fact that bats have more T cells than B cells in the blood and spleen ([@bb0085]), and their antibodies have been shown to have lower avidity and form a weaker association with antigens ([@bb0115]), which would explain the absence or low titers of neutralizing antibodies following infection with certain viruses, as in the case of wild-caught *Epitesicus fuscus* bats that were positive for *Epitesicus fuscus* gammaherpesvirus (EfHV) but did not contain neutralizing antibodies against the virus ([@bb0570]). All of this suggest that the antibodies produced by bats may control viral infections via an unknown mechanism that does not involve virus neutralization ([@bb0070]; [@bb0085]) and still needs to be elucidated by future research efforts.

Exposures to infected urine has also been suggested as a possible route of transmission of some viruses from bats, as in the case of Hendra virus, in which the virus is likely transmitted to horses via ingestion of food, pasture or water contaminated with urine, saliva and feces of infected bats ([@bb0040]; [@bb0600]), as well as Rabies virus, for which bat urine and feces have been suggested as a source of infection and a possible mode of transmission ([@bb0035]). They may also transmit viruses to human and other animals through bites and scratches like it happens with rabies ([@bb0160]). It is also worth mentioning that consumption and handling of undercooked bat meat is still practiced in China and some parts of Asia ([@bb0115]; [@bb0625]), increasing the possibilities of direct transmission from bat to humans.

6. Conclusions and perspectives for the future {#s0055}
==============================================

We are now aware of the great genetic diversity of bat coronaviruses and the threat to public health these unknown viruses represent when they cross the species barrier and cause outbreaks of dangerous novel diseases such as COVID-19. It is therefore essential to understand in detail the distribution of bats as reservoir hosts, and the interaction between animals and between humans and animals. Research should be focused on the genetic diversity of bat-borne viruses to prevent future outbreaks, and efforts should also be made on real-time surveillance of potentially zoonotic viruses in bat populations and wet-markets as COVID-19 was neither the first nor the last disease to jump from animals to humans in these settings.

One of the lessons we have learned from SARS, MERS and COVID-19 is that detailed molecular analysis of their S protein, its RBD and host receptors will be the key to understand the whole molecular mechanism involved in cross-host transmission of these viruses. It is also important that more details about bats immune response to persistent viral infections are elucidated, particularly regarding adaptive immunity, as this would allow for a better understanding of the relationship between these viruses and their reservoir hosts and allow us to be better prepared or even prevent the emergence of novel diseases like this in the future.

Moreover, the world could benefit from implementing One Health approaches in aspects involving animals, the environment and humans. Taking into consideration that the last three major zoonotic spillovers of coronaviruses from wild animals to humans resulted from the close contact between humans and wildlife, we could say that human health is closely related to animal and environmental health. Which is why integrating the One Health approach to the mitigation strategies currently used in controlling new disease outbreaks could contribute substantially to the control of SARS-CoV-2, as well as many other novel infectious diseases that might emerge the near future.
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